SAVING LIVES WITH AI

The new “Claude Science” from Anthropic uses artificial intelligence to tackle rare genetic disorders and tropical maladies, the kind that are usually ignored because there aren’t enough patients to justify the costs involved in finding a cure. It sounds almost miraculous but it can’t do human testing. So the company is hoping it will be a helpful tool for anyone from giant pharmaceutical companies down to individual researchers.The beta version is available to paid Claude users (currently macOS/Linux) starting at $20 a month. However, the field is ripe with competitors. Insilico Medicine, Recursion, Exscientia and Isomorphic Labs are all involved in AI drug discovery. In July 2026, Insilico launched a Phase III trial for “Rentosertib,” an oral medication for idiopathic […]

Read more